甲状腺眼病眼眶组织的多中心、单盲、病例对照免疫组化研究
多中心单盲病例对照研究纳入60份眼眶组织标本(44例甲状腺眼病患者、16例对照),用18种抗体免疫组化检测。活动期患者淋巴细胞浸润明显,17/18种抗体在患者眼眶结缔组织中高表达,TSH-R、IGF-1R、CD40/CD40L等与临床活动度评分及TSH-R刺激抗体浓度正相关,与病程负相关。
要点
- 活动期甲状腺眼病眼眶组织淋巴细胞浸润明显,非活动期程度较轻,对照无浸润。
- 17/18种抗体在甲状腺眼病患者眼眶结缔组织中高表达,仅CD20例外。
- 眼眶放疗降低TSH-R表达(p<0.001)和IGF-1R表达(p=0.012)。
核心结论
- 适应性免疫和细胞介导免疫、TSH-R/IGF-1R及CD40/CD40L过表达是甲状腺眼病的相关病理机制。
- 针对活动期这些关键分子可提供特异且新颖的治疗途径。
研究设计与样本
- 多中心、单盲、病例对照研究,共采集60份眼眶组织标本,来自眼眶减压术(44例甲状腺眼病患者)或非甲状腺眼病相关眼整形手术(16例对照)。
- 组织经福尔马林固定和石蜡包埋保存,切片用微聚合物标记技术以18种抗体免疫组化染色。
- 免疫染色玻片经Panoramic Desk扫描并由用户独立查看软件盲法评估。
主要发现
- 临床活动期甲状腺眼病患者(n=22)眼眶组织标本可见明显淋巴细胞浸润,非活动期(n=22)程度轻得多,对照无淋巴细胞浸润。
- 所有样本均见血管增多,临床活动期标本伴眼眶充血;甲状腺眼病样本存在组织纤维化,对照无纤维化。
- 与对照相比,除CD20外,18种抗体中17种在甲状腺眼病患者眼眶结缔组织中高表达。
- TSH-R、IGF-1R、CD40、CD40L、CD3、CD68、IL-17A、IL-23A、IL-1β、IL-4、RANTES、MCP-1、IL-16和BAFF在临床活动期甲状腺眼病中过表达(均p<0.001)。
- CD40L、IL-17A、IL-23A、IL-6、IL-1β、RANTES和BAFF表达在活动期甲状腺眼病(TED/对照比值>3)、非活动期甲状腺眼病和对照中分别呈很高(p<0.001)、中等(比值>2)和低水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid eye disease (TED) involves several pathogenic pathways and a battery of infiltrating mononuclear cells, cytokines, and chemokines in the orbit. Revealing the main molecules, which play a major role in the pathogenesis of TED, will help developing novel treatment strategies. Methods: In a multicenter, single-blind, case-control study, 60 tissue samples were collected during orbital decompression (44 TED patients) or non-TED related oculoplastic (16 controls) surgeries. Formalin-fixation and paraffin embedding preserved orbital tissue. Tissue sections were immunostained with 18 antibodies by the micro-polymer labeling technique. Immunostaining slides were scanned by Panoramic Desk and blindly evaluated by a user-independent viewer software. Results: Marked lymphocyte infiltration was observed in orbital tissue specimens of patients with clinically active TED (n = 22) and to a much lesser extent in inactive cases (n = 22), while it was absent in controls. Increased vascularity was noted in all samples, with orbital congestion in specimens of clinically active TED. Tissue fibrosis was present in TED samples but not in controls. Immunohistochemistry of orbital tissue clearly differentiated between TED and controls, as well as between active and inactive TED. In contrast to controls and with the exception of cluster of differentiation 20 (CD20), 17 out of 18 antibodies were highly expressed in orbital connective tissue of TED patients. Especially, thyrotropin receptor (TSH-R), insulin-like growth factor 1 receptor (IGF-1R), CD40, cluster of differentiation 40 ligand (CD40L), CD3, CD68, interleukin-17A (IL-17A), IL-23A, IL-1β, IL-4, regulated on activation, normal T cell expressed and secreted (RANTES), macrophage chemoattractant protein 1 (MCP-1), IL-16, and B cell activating factor (BAFF) were overexpressed in clinically active TED (all p < 0.001). Also, the expression of CD40L, IL-17A, IL-23A, IL-6, IL-1β, RANTES, and BAFF was very high (TED/control ratio >3), moderate (ratio >2), and low in active (p < 0.001), inactive TED and controls, respectively. The expression of TSH-R, IGF-1R, CD40, CD40L, CD3, CD68, CD20, IL-17A, IL-23A, RANTES, MCP-1, and BAFF positively and significantly correlated with both serum TSH-R stimulatory antibody concentrations and clinical activity scores while it negatively correlated with TED duration. Orbital irradiation decreased TSH-R (p < 0.001) and IGF-1R expression (p = 0.012); in contrast, neither smoking, age, nor gender did impact immunohistochemical staining. Conclusions: Adaptive and cell-mediated immunity, overexpression of TSH-R/IGF-1R and CD40/CD40L are the relevant pathomechanisms in TED. Targeting these key players in the active phase of the disease offers specific and novel treatment approaches.
引用
- Hai YP, Saeed MEM, Ponto KA, et al. A Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease. Thyroid. 2022. PMID: 36128805. doi:10.1089/thy.2022.0173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。